Revenue
934 million USD
2011-09-30 · USD
Exact inputs and evidence
- Revenue: 933900000 USD Source
Fundies. English
Mead Johnson Nutrition Co
EDGAR37 filing records in this dataset, filed from 2009-03-27 to 2017-04-27. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Net margin
15.49%
2011 Q3 · %
Operating cash flow
168 million USD
2011-09-30 · USD
- Cash and cash equivalents
- 1.72 billion USD Source
Exact value
1724400000 USD
- Long-term debt including current maturities
- 3.01 billion USD Source
Exact value
3008400000 USD
- Shares outstanding
- Not available
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
592 million USD
2016-04-01 – 2017-03-31
Operating cash flow
728 million USD
2016-04-01 – 2017-03-31
Exact inputs and evidence
- Operating cash flow: 276100000 USD · 2016-01-01 – 2016-06-30 Source
- Operating cash flow: 160100000 USD · 2016-01-01 – 2016-03-31 Source
- Operating cash flow: 510700000 USD · 2016-01-01 – 2016-09-30 Source
- Operating cash flow: 276100000 USD · 2016-01-01 – 2016-06-30 Source
- Operating cash flow: 691600000 USD · 2016-01-01 – 2016-12-31 Source
- Operating cash flow: 510700000 USD · 2016-01-01 – 2016-09-30 Source
- Operating cash flow: 196400000 USD · 2017-01-01 – 2017-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2017-04-27.
Financial data available through: 2016-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 8 of 11 periods available· newest 2016-12-31
- Operating cash flow: 8 of 11 periods available· newest 2016-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 8 of 11 periods available· newest 2016-12-31
- Total liabilities: 8 of 11 periods available· newest 2016-12-31
- Current assets: 8 of 11 periods available· newest 2016-12-31
- Current liabilities: 8 of 11 periods available· newest 2016-12-31
- Cash and cash equivalents: 8 of 11 periods available· newest 2016-12-31
- Long-term debt including current maturities: 2 of 11 periods available· newest 2015-12-31
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
-16.6%Prior period
USD 653.5 million
–
Current period
USD 544.9 million
–
Exact inputs and evidence
544900000 − 653500000 = -108600000 USD
653500000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source544900000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-24%Prior period
USD 909.9 million
–
Current period
USD 691.6 million
–
Exact inputs and evidence
691600000 − 909900000 = -218300000 USD
909900000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source691600000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2009 2009-01-01 – 2009-12-31 | USD 399.6 million Exact valueExact value: 399600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 576.6 million Exact valueExact value: 576600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2010 2010-01-01 – 2010-12-31 | USD 452.7 million Exact valueExact value: 452700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 514.2 million Exact valueExact value: 514200000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2011 2011-01-01 – 2011-12-31 | USD 508.5 million Exact valueExact value: 508500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 632.8 million Exact valueExact value: 632800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2012 2012-01-01 – 2012-12-31 | USD 580.4 million Exact valueExact value: 580400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 692.7 million Exact valueExact value: 692700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2013 2013-01-01 – 2013-12-31 | USD 683.8 million Exact valueExact value: 683800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 806.6 million Exact valueExact value: 806600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2014 2014-01-01 – 2014-12-31 | USD 719.8 million Exact valueExact value: 719800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 793.4 million Exact valueExact value: 793400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2015-01-01 – 2015-12-31 | USD 653.5 million Exact valueExact value: 653500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 909.9 million Exact valueExact value: 909900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2016-01-01 – 2016-12-31 | USD 544.9 million Exact valueExact value: 544900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 691.6 million Exact valueExact value: 691600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
37 filings · 1,971 latest values · 1,971 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001452575, 1452575, edgar:1452575, mjn
Also known as Mead Johnson Nutrition Co